MEDICAL BIOLOGIC WARFARE DEFENSE

File: 123096_sep96_decls30_0032.txt
Page: 0032
Total Pages: 34

Subject: MEDICAL BIOLOGIC WARFARE DEFENSE                                

Unit: OTSG        

Parent Organization: HSC         

Box  ID: BX003203

Folder Title: MED BIO WARFARE DEFENSE INFORMATION PAPER AND SLIDES                                            

Document Number:          1

Folder Seq  #:        246



                         UNCLASSIFIED


                                 DEPARTMENT OF THE ARMY
                                OFFICE OF THE SURGEON GENERAL
                                     5109 LEESBURG PIKE
                                  FALLS CHURCH, VA 22041-3258
               REPLY TO
               ATTENTION OF

         SGPS-ZA (50)


         MEMORANDUM FOR OFFICE OF THE DEPUTY CHIEF OF STAFF FOR
                           OPERATIONS AND PLANS, WASHINGTON, DC 20310

         SUBJECT: Vaccine Policy Recommendation


         1. (U) Reference: Memorandum, HQDA (ODCSOPS), DAMO-SW,
         9 September 1991, Subject: Minutes of the Biological Defense
         committee Meeting, 29 August 1991, Memorandum 3-91. (U)

         2. (U) This memorandum provides information for ODCSOPS and
         the Biological Defense Committee to make a vaccine policy
         recommendation.


         3.        The facts are:

               a.        In FY92, the United States can only vaccinate



               b.        In FY93, an additional              an be vaccinated
         against anthrax. The level of production of botulinum toxoid in
         FY93 is uncertain.

               c.        By FY94, increased production of both vaccines will
         begin.

                   (1)        The Army indemnified the National Cancer
         Institute (NCI) for the production of anthrax. Production
         estimates should allow DoD to protect           131            against
         anthrax. (NCI production rate estimated to be
         doses per year.)

                         (a) (U) This allows Michigan Department of Public
         Health (MDPH) to transfer its effort to produce botulinum toxoid.

                         (b)       The combined production effort of Porton,
         U.S. Army Medical Research Institute of Infectious Diseases and
         MDPH is expected to yield enough vaccine to protect
         against botulinuia per year. (Production rate estima
         doses per year.)

        (2)        Based on current projections, a vaccinated
         force of                                                       can
         be maintained by FY97. The e projections are based on maximum

Document 34 f:/Week-36/BX003203/MED BIO WARFARE DEFENSE INFORMATION PAPER AND SLIDES/medical biologic warfare defense:12179609282531
Control Fields 17
File Room = sep96_declassified
File Cabinet = Week-36
Box ID = BX003203
Unit = OTSG
Parent Organization = HSC
Folder Title = MED BIO WARFARE DEFENSE INFORMATION PAPER AND SLIDES
Folder Seq # = 246
Subject = MEDICAL BIOLOGIC WARFARE DEFENSE
Document Seq # = 1
Document Date =
Scan Date =
Queued for Declassification = 01-JAN-1980
Short Term Referral = 01-JAN-1980
Long Term Referral = 01-JAN-1980
Permanent Referral = 01-JAN-1980
Non-Health Related Document = 01-JAN-1980
Declassified = 17-DEC-1996